Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial.
about
The PROMIS fatigue item bank has good measurement properties in patients with fibromyalgia and severe fatigue.Multidimensional daily diary of fatigue-fibromyalgia-17 items (MDF-fibro-17). part 1: development and content validity.Multidimensional daily diary of fatigue-fibromyalgia-17 items (MDF-fibro-17): part 2 psychometric evaluation in fibromyalgia patientsManagement of fibromyalgia syndrome: review of evidence.OMERACT-based fibromyalgia symptom subgroups: an exploratory cluster analysisAn update on pharmacotherapy for the treatment of fibromyalgia.Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program.Duloxetine in panic disorder with somatic gastric pain.Beyond pain in fibromyalgia: insights into the symptom of fatigue.A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain.The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain.Preliminary analysis of mortality associated with rituximab use in autoimmune diseases.Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations.Challenges of implementing fibromyalgia treatment guidelines in current clinical practice.Symptoms and Functional Limitations in the First Year Following a Myocardial Infarction: A Qualitative Study.Current treatments to counter sleep dysfunction as a pathogenic stimulus of fibromyalgia.A Brief Review of the Pharmacology of Amitriptyline and Clinical Outcomes in Treating Fibromyalgia.Longitudinal stability of fibromyalgia symptom clusters.
P2860
Q33458953-8D8B29CF-06EC-4F33-9EE8-47AD55AAF2F0Q33697204-55B65750-ACCE-4893-B0E0-81F730828842Q33706811-419F46E5-30FD-4F83-9B10-7621EB3DE158Q33938302-9A44D020-4006-4399-BC55-27E40BD7E363Q34459831-879C101D-61EF-486B-83A7-229940264638Q34477510-823CE118-1919-4A3C-B111-D7313E938765Q35780920-C03CF475-363B-4643-BBF7-F54463268909Q37347060-9888E0FE-DD6B-4BED-B07A-DFCD6BAD9DCBQ37690090-1B8B0FE4-BBBD-4941-B69F-6EDB0E04952FQ38020236-37DB8539-9406-4F3C-9680-55D8F946CEC3Q38086926-C765C061-5525-4453-930E-2D9A85826989Q38154934-119B54C0-773A-4FB9-9F8A-965D00C0AAF2Q38827493-66895994-3BF2-486A-B9F2-08DDCA6048B2Q39340760-B43A6A1E-D335-410B-A8A4-9F82064B99A6Q47398731-D1EFAD71-8C26-4636-B7A3-FC9E4C2DDD95Q47845604-9A8744A3-3973-4A29-BF0A-A98A2BE13C6DQ52641632-A4C8068C-3A20-4918-B2D4-F43B1272FC6BQ52682704-D6814374-6278-40A6-BB22-7FCAC93C09C5
P2860
Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Improvement in multiple dimens ...... zed, placebo-controlled trial.
@ast
Improvement in multiple dimens ...... zed, placebo-controlled trial.
@en
type
label
Improvement in multiple dimens ...... zed, placebo-controlled trial.
@ast
Improvement in multiple dimens ...... zed, placebo-controlled trial.
@en
prefLabel
Improvement in multiple dimens ...... zed, placebo-controlled trial.
@ast
Improvement in multiple dimens ...... zed, placebo-controlled trial.
@en
P2093
P2860
P356
P1476
Improvement in multiple dimens ...... zed, placebo-controlled trial.
@en
P2093
Fujun Wang
Madelaine M Wohlreich
Paula J Gaynor
P2860
P2888
P356
10.1186/AR3359
P577
2011-06-13T00:00:00Z
P5875
P6179
1018349972